Improved Metacam® Chewable Tablets Launched

Boehringer Ingelheim Vetmedica has launched new and improved Metacam® Chewable Tablets in an appetising, meaty flavour. The easy-to-administer tablets are proven to be taken by 90% of dogs voluntarily¹ and 80% will even take them from the floor1 which aids compliance. Available in handy pop-through blister strips of seven for easy dispensing and administration, the 1mg and 2.5mg Metacam Chewable Tablets are packed in boxes of 84 and priced the same per tablet as the current tablet range. Claire Fowler, companion animal marketing manager at Boehringer Ingelheim, says: “The existing Metacam Chewable Tablets are readily accepted by most dogs. However, to appeal to as many dogs as possible, we have launched an even more appetising ‘beefed up’ meaty flavour.” For further information on the new flavoured Metacam tablets, including special offers, please contact your Boehringer Ingelheim territory manager or call 01344 746959. References 1. Boehringer Ingelheim Study VU-01988. Cross-over randomised, blinded study in 47 pet (not laboratory) dogs. Mixed population of sizes, sexes and breeds. Length of study – six days.

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards